The European aesthetic injectable market will grow rapidly through 2028, driven by increasing penetration into new patient groups, such as men and younger patients, major mergers and acquisitions, and new product launches and innovations. However, growth will decelerate in the later half of the forecast period to some extent, due largely to an increase in price-based competition as the market matures.
This Medtech 360 Report provides high-level market metrics for aesthetic injectables in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
- Aesthetic Injectables - Market Insights - Europe (Supplemental)
Author(s): Raghav Tangri, MRes
Raghav Tangri is a senior analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in aesthetics device markets. Raghav has been featured in the Aesthetics Journal and has participated in several white papers on policy advocacy and analysis. Raghav also has expertise in the endoscopy device space, including the markets for gastrointestinal devices, open and laparoscopic devices, and hernia repair devices. Raghav holds a Bachelor's degree in Biotechnology from Delhi Technological University and a Master's degree in Life Sciences from Imperial College London.
Follow Raghav on Twitter:@rtangri_DRG